100 related articles for article (PubMed ID: 11840277)
1. High incidence of point mutations of p53 suppressor oncogene in patients with myelodysplastic syndrome among atomic-bomb survivors: a 10-year follow-up.
Imamura N; Abe K; Oguma N
Leukemia; 2002 Jan; 16(1):154-6. PubMed ID: 11840277
[No Abstract] [Full Text] [Related]
2. Oncogene mutation and prognosis in the myelodysplastic syndromes.
Padua RA; West RR
Br J Haematol; 2000 Dec; 111(3):873-4. PubMed ID: 11122149
[TBL] [Abstract][Full Text] [Related]
3. P53 mutations in myelodysplastic syndromes.
Ludwig L; Schulz AS; Janssen JW; Grünewald K; Bartram CR
Leukemia; 1992 Dec; 6(12):1302-4. PubMed ID: 1453775
[TBL] [Abstract][Full Text] [Related]
4. [Chromosome 1 abnormalities at band 1p32 in two atomic bomb survivors with myelodysplastic syndrome].
Nakamura H; Hata T; Tagawa M; Atogami S; Tomonaga M; Sadamori N; Hayashi Y
Rinsho Ketsueki; 2000 Feb; 41(2):152-8. PubMed ID: 10723246
[TBL] [Abstract][Full Text] [Related]
5. No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndromes.
Mitani K; Hangaishi A; Imamura N; Miyagawa K; Ogawa S; Kanda Y; Yazaki Y; Hirai H
Leukemia; 1997 Jun; 11(6):863-5. PubMed ID: 9177441
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiology of leukemia and MDS among atomic bomb survivors in Hiroshima and Nagasaki suggests how abnormal epigenetic regulation contributes to leukemogenesis].
Inaba T
Rinsho Ketsueki; 2009 Oct; 50(10):1548-52. PubMed ID: 19915365
[No Abstract] [Full Text] [Related]
7. Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.
Lorenzo F; Nishii K; Monma F; Kuwagata S; Usui E; Shiku H
Leuk Res; 2006 Oct; 30(10):1235-9. PubMed ID: 16533529
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
Ghaddar HM; Stass SA; Pierce S; Estey EH
Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
[TBL] [Abstract][Full Text] [Related]
9. Chromosome abnormalities in the myelodysplastic syndromes.
Heim S; Mitelman F
Clin Haematol; 1986 Nov; 15(4):1003-21. PubMed ID: 3552345
[No Abstract] [Full Text] [Related]
10. Cancer risks and biomarker studies in the atomic bomb survivors.
Preston D
Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
[TBL] [Abstract][Full Text] [Related]
11. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome.
Misawa S; Horiike S; Kaneko H; Kashima K
Leukemia; 1997 Apr; 11 Suppl 3():533-5. PubMed ID: 9209448
[TBL] [Abstract][Full Text] [Related]
12. The 5q- syndrome.
Van den Berghe H
Scand J Haematol Suppl; 1986; 45():78-81. PubMed ID: 3457446
[No Abstract] [Full Text] [Related]
13. Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Remacha AF; Nomdedéu JF; Puget G; Estivill C; Sarda MP; Canals C; Aventin A
Haematologica; 2006 May; 91(5):719-20. PubMed ID: 16670082
[TBL] [Abstract][Full Text] [Related]
14. [Chromosome changes in refractory anemia: a report of 15 cases].
Sun BZ; Yang JZ; Shen SY
Zhonghua Nei Ke Za Zhi; 1986 Jan; 25(1):7-9, 62. PubMed ID: 3731954
[No Abstract] [Full Text] [Related]
15. Chromosome studies in human hematologic diseases: II. Myelodysplastic syndromes.
Larripa I; Labal de Vinuesa M; Bengiò R; Slavutsky I
Haematologica; 1987; 72(5):399-403. PubMed ID: 3121461
[No Abstract] [Full Text] [Related]
16. Approaches for studying radiation-induced leukemia.
Gluzman DF
Stem Cells; 1997; 15 Suppl 2():243-9. PubMed ID: 9368309
[TBL] [Abstract][Full Text] [Related]
17. N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome.
Horiike S; Misawa S; Nakai H; Kaneko H; Yokota S; Taniwaki M; Yamane Y; Inazawa J; Abe T; Kashima K
Leukemia; 1994 Aug; 8(8):1331-6. PubMed ID: 8057669
[TBL] [Abstract][Full Text] [Related]
18. Comments on the paper: Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors--a biological perspective.
Plumb M
Int J Radiat Biol; 2003 May; 79(5):367-70; author reply 371-4. PubMed ID: 12943245
[No Abstract] [Full Text] [Related]
19. Myelodysplastic syndromes: natural history and features of prognostic importance.
Mufti GJ; Galton DA
Clin Haematol; 1986 Nov; 15(4):953-71. PubMed ID: 3552350
[No Abstract] [Full Text] [Related]
20. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
